Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway

• Zhen-Hua Wu ,

  Contributed equally to this work with: Zhen-Hua Wu, Chen Lin

  Affiliation Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Chen Lin ,

  Contributed equally to this work with: Zhen-Hua Wu, Chen Lin

  Affiliation Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Ming-Ming Liu,

  Affiliation Department of Medical Chemistry, School of Pharmacy, Fudan University, Shanghai, China

  ⨯
• Jian Zhang,

  Affiliation Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Zhong-Hua Tao,

  Affiliation Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Xi-Chun Hu

  * E-mail: xchu2009@hotmail.com.

  Affiliation Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯